baber/WOPTO huggingface dataset:
Patent DK-0465536-T3 (DK)
Inventor: BARTH GUENTHER
IPC: E01C9/00
Filed: 1990-04-03
Granted: 1994-05-30
Abstract: PCT No. PCT/EP90/00526 Sec. 371 Date Dec. 3, 1992 Sec. 102(e) Date Dec. 3, 1992 PCT Filed Apr. 3, 1990 PCT Pub. No. WO90/12152 PCT Pub. Date Oct. 18, 1990.An angular paving stone (2) for paving areas, comprising two outer sides (16), two inner sides (18) and two face sides (20). At the five outer corners (4) of the angular paving stone (2) there are provided quarter recesses (22). At the center of the outer sides (16) of the angular paving stone (2) there are provided half recesses (24). At the inner corner (6) of the angular paving stone (2) there is provided a three-quarter recess (26). The partial recesses (22, 24, 26) supplement each other in the paved area so as to form full recesses (38) for water discharge.
Patent DK-0484421-T3 (DK)
Inventor: GAPE ALAN FREDERICK BOSKERNOW
IPC: A61H33/02
Filed: 1990-08-02
Granted: 1995-05-29
Abstract: PCT No. PCT/GB90/01208 Sec. 371 Date Jan. 31, 1992 Sec. 102(e) Date Jan. 31, 1992 PCT Filed Aug. 2, 1990 PCT Pub. No. WO91/01675 PCT Pub. Date Feb. 21, 1991.The fixed-direction jet units (1) of a whirlpool-bath system each include a nozzle (18) for supplying water under pressure from a tube-section (17) to an outlet (12) across an air gap (20) within a chamber (19). The unit (1) is clamped to the bath-wall (14) between a flange (16) of the outlet (12) and the unit housing (15). The flow of water from the nozzle (18) across the gap (20) into the axially-aligned stem (13) of the outlet (12) draws air into the chamber (19) from an inlet pipe (21) that is coupled to a distribution manifold (7) of an air-supply controller (9) by an individual supply tube (8). A circumferential skirt (22) projects backwardly from the stem (13) to shroud the gap (20) over a frusto-conical nose-part (23) of the nozzle (18), so that air is constricted to enter the gap (20) through the annular space (24) between them. The constriction evens out air flow around the stream of water from the nozzle (18), enhancing small-bubble distribution in the stream and the consequent foaming and turbulence of the jet discharged from the outlet (12). The cross-sectional area of the pathway for air between the nozzle nose-part (23) and the skirt (22) increases towards the gap (20), but may be substantially uniform.
Patent DK-0519922-T3 (DK)
Inventor: GUERINEAU JEAN
IPC: A61M5/31
Filed: 1990-07-27
Granted: 1995-04-18
Abstract: PCT No. PCT/FR90/00572 Sec. 371 Date Sep. 4, 1992 Sec. 102(e) Date Sep. 4, 1992 PCT Filed Jul. 27, 1990 PCT Pub. No. WO91/13643 PCT Pub. Date Sep. 19, 1991.A syringe comprises a body (1) which carries the needle (6), a piston (13), a protective sheath and a spring (17) arranged between the sheath (14) and the body (1). A first and a second shoulder (21) on the outer wall of the body (1) co-operate with a first spur (19) of the sheath (14) to block the body (1) in a first direction, which a second, supple spur (20) and a third shoulder (24) block the body (1) in the other direction.
Patent DK-0454807-T3 (DK)
Inventor: WATTIE JAMES ALISTAIR
IPC: A47G9/10
Filed: 1990-11-01
Granted: 1994-01-24
Abstract: A pillow is of rectangular form and formed by adhering together a top part and base part, the top part being of a softer material than that of the base part. The base part has front and rear rolls at its longer sides and side rolls at its shorter sides, upper and lower surfaces of the pillow having respective large, central recessed areas between the front and rear rolls, the rolls being interrupted by minor recesses extending from respective sides of the pillow into the central recessed areas of the upper and lower surfaces respectively, the front and rear rolls forming on each surface a central main buttress and together with the side rolls forming four corner buttresses, side buttresses also being formed between pairs of adjacent corner buttresses respectively, the side buttresses tapering in width and height away from their respective associated sides of the pillow into a central recessed area. The whole of the upper surface of the top part is smooth and its lower surface is adhered to the upper surface of the top part only around their respective perimeters. A large, central void space is defined between the top and base parts in an undeformed state of the pillow.
Patent DK-0516885-T3 (DK)
Inventor: DEPIERNE OTTO S
IPC: D21H17/35
Filed: 1991-12-19
Granted: 1996-04-15
Abstract: A process is disclosed for the preparation of styrene/acrylic type polymers which are useful in the sizing of paper. The process comprises polymerizing the monomers in an alcohol/water mixture at reflux temperature in the presence of a free-radical generating catalyst. The catalyst is added portion-wise over the course of the reaction and the resultant polymer is neutralized while substantially simulaneously separating the alcohol/water mixture and adding water to recover a product of less than 25% polymer solids.
Patent DK-0486140-T3 (DK)
Inventor: JORDAN JEFF P
IPC: C02F11/04
Filed: 1991-09-23
Granted: 1996-09-16
Abstract: An anaerobic digester for digesting animal manure and other biologically degradable material contains support media (50) for enhancing the contact between the microbes in the digesting mass and the available nutrients, The digester includes a novel fluid circulation and distribution systems. The distribution system prevents build up of heavy material in the bottom of the digester and prevents agglomeration of light material at the top of the digester. The digesting fluid travels over a floating weir (64) into an intake and impeller assembly (68). The impeller drives the fluid through a conduit (80) located adjacent the floor of the digester. Nozzles (98) in the conduit project the fluid downwardly toward the floor thus causing a sweeping action on the floor. Fluid then flows upwardly past the support media. Risers (86, 88, 94) are provided at the ends of the conduit, which terminate in nozzles (90, 92, 96) at the surface of the digesting liquid. The nozzles direct the flow of digesting material back toward the fluid inlet and also sweep the corners of the digester to prevent material accumulation. <IMAGE>
Patent DK-0455620-T3 (DK)
Inventor: STANLEY SAMUEL LEONARD JR
IPC: C07K19/00
Filed: 1991-04-29
Granted: 1995-12-11
Abstract: An Entamoeba histolytica specific cDNA clone which encodes an antigenic surface membrane protein possessing multiple tandem repeats and expression in E. coli is disclosed.
Patent DK-0527804-T3 (DK)
Inventor: FUNG YUEN KAI
IPC: A61K48/00
Filed: 1991-04-10
Granted: 2000-06-05
Abstract: A pharmaceutical composition for the treatment of pathological cellular proliferative diseases by administration to a cell comprises a negative growth regulatory gene which directs the expression of an encoded peptide. Typically the composition comprises DNA which encodes the negative growth regulatory gene which DNA is contained within a recombinant expression vector.
Patent DK-0593820-T3 (DK)
Inventor: DEKKER NICOLAAS PETRUS
IPC: G09F11/23
Filed: 1992-10-23
Granted: 1998-05-11
Abstract: Hinged or rotating connection between elements closely placed on one another, in particular of cardboard or pasteboard, with two outer elements and at least one inner element placed in between, while in an outer element a cylindrical protuberance is formed, over which the inner element, which is provided with a hole, is mounted and which inner element may hinge or rotate around it, while the upper plane of the protuberance is glued to the second outer element. <IMAGE>
Patent DK-0584145-T3 (DK)
Inventor: BROECKHOVEN CHRISTINE VAN
IPC: C12Q1/6883
Filed: 1992-05-06
Granted: 2000-04-25
Abstract: Process for the in vitro diagnosis of chromosomal anomalies liable to be correlated with CMT1a disease, probes intended in this in vitro diagnosis process and kits containing said probes. The probes can obtain a sequence constituted of from about 15 successive nucleotides of NotI fragment, with said NotI fragment having 1.2 x 10<6> base pairs and being obtained after digesting human DNA of patients with NotI, separating the fragments resulting from digestion by pulsed field gel electrophoresis and hybridizing the resulting fragments with any of the probes VAW409, EW401 or VAW412 or their derivatives, to about the total number of the successive nucleotides of the NotI fragment. The probes enable the detection of the duplication of a part of chromosome 17p.
Patent DK-0577763-T3 (DK)
Inventor: GIANNINI DENNIS ALBERT
IPC: B65D19/20
Filed: 1992-03-25
Granted: 1995-05-08
Abstract: A modular shipping container and a clip for use therein to interconnect various components of the container, such as the sidewalls, bottom pallet, and top pallet. The container components are designed for compact storage and easy assembly. The clip used in the container includes a first portion for affixing the clip to the sidewall structure and a second portion having a rigid arm extending from the first portion. A resilient flex arm is attached to the end of the rigid arm farthest the first portion and extends generally toward the first portion. The flex arm has a locking face thereon for engaging an edge of a receiving slot in the pallet. Insertion of the clip into the receiving slot removably interconnects the sidewall structure to the pallet.
Patent DK-0596036-T3 (DK)
Inventor: HAAK RONALD P
IPC: A61K9/00
Filed: 1992-07-22
Granted: 1995-12-04
Abstract: A transdermal drug delivery device (20) is provided having both an active drug reservoir (24) and a passive drug reservoir (26). Drug is actively delivered by iontophoresis from the active drug reservoir (24) by an electric field generated by a power source (21). Simultaneously, drug is delivered from passive reservoir (26) by passive (i.e., non-electrically assisted) diffusion. In one embodiment, the passive drug reservoir (26) is electrically insulated from the active drug reservoir (24). In a second embodiment, both the active and the passive drug are contained in the same reservoir (34). In the second embodiment, the active drug is ionizable while the passive drug is non-ionizable. Most preferably, the active drug is an ionizable form (i.e., a salt form) of the passive drug.
Patent DK-0567227-T3 (DK)
Inventor: RANSON JOHN
IPC: B22D41/20
Filed: 1993-03-23
Granted: 1996-07-22
Abstract: A stopper device (46) for use in molten-metal auto-pouring apparatus (10) comprising an attachment part (49) constructed to be releasably fixedly attached to a stopper device operator of such apparatus and a stopper support part (50) adjustably connected to the attachment part so as to permit a degree of movement therebetween. Locking means (76, 78, and 80) are provided to enable the stopper support part (50) to be retained in a given position relative to the attachment part (49). As a result, when the device is prepared for use, and the attachment part (49) is fixedly attached to such an operator, the latter operates to move the device downwardly so that a lower end of a stopper mounted on the stopper support part (50) engages the outlet of the apparatus, the said degree of movement enabling that end to be seated properly in the outlet, whereupon the locking means (76, 78, and 80) are used to retain the resulting position of the stopper support part (50) relative to the attachment part (49) to ensure that the stopper will be properly seated after subsequently being raised and lowered. <IMAGE>
Patent DK-0646116-T3 (DK)
Inventor: URBAN FRANK J
IPC: C07D471/04
Filed: 1993-02-16
Granted: 1999-12-27
Abstract: PCT No. PCT/US93/01208 Sec. 371 Date Dec. 12, 1994 Sec. 102(e) Date Dec. 12, 1994 PCT Filed Feb. 16, 1993 PCT Pub. No. WO93/25552 PCT Pub. Date Dec. 23, 1993   <IMAGE>  (1)   <IMAGE>  (2)   <IMAGE>  (3)   <IMAGE>  (4)   <IMAGE>  (5)  Optically pure intermediates of formula (1) wherein the substituent B is either cis or trans to the C9a-C1 bond and is selected from the group consisting of -CH2OH, -CHO, -CH2OSO2R, -CH2CN, -CH(OH)CH2NO2, -CH=CH-NO2, (2) and (3), C is selected from the group consisting of -H, (4), (5), and a nitrogen protecting group which is removable by hydrogenation or acid treatment; and wherein R is (C1-C8) alkyl, phenyl or alkyl substituted phenyl; X is N or CH; Y is O or S and Z is H or Cl; for the synthesis of octahydro-1H-pyrido(1,2-a)pyrazinyl ethyl carboxamide anxiolytic agents.
Patent DK-0674508-T3 (DK)
Inventor: BUTTERFIELD WILLIAM JOHN HUGHE
IPC: A61P9/08
Filed: 1993-12-17
Granted: 1999-03-22
Abstract: PCT No. PCT/GB93/02576 Sec. 371 Date Jun. 16, 1995 Sec. 102(e) Date Jun. 16, 1995 PCT Filed Dec. 17, 1993 PCT Pub. No. WO94/13276 PCT Pub. Date Jun. 23, 1994The subject invention pertains to methods of using 4-guanidinobutyramide, or a physiologically-acceptable salt thereof, in a mammal or human to improve blood circulation.
Patent DK-0655117-T3 (DK)
Inventor: CORBISHLEY TERRENCE JEFFREY
IPC: F16L1/16
Filed: 1993-08-10
Granted: 1997-12-22
Abstract: The invention relates to improvements in an apparatus, such as pipelines (2) and associated equipment and to a method of making, insulating, providing buoyancy to, recovering and installing submarine apparatus. The marine or submarine apparatus comprises an impermeable enclosure (1) associated with the apparatus (2), which enclosure is tightly packed with hollow microspheres (3) to a density where, when submerged in use, the internal pressure of the microspheres is greater than or substantially equal to the water pressure on the apparatus.
Patent DK-0688784-T3 (DK)
Inventor: UHLMANN EUGEN DR
IPC: A61K48/00
Filed: 1995-06-09
Granted: 2006-04-18
Abstract: 3'-Derivatised oligonucleotide analogues of formula (I) and (II) and their salts are new: R<1>-(A<1>)n'-(B<1>)m'-(A<2>)n-(B<2>)m-B<3> (I); R<1>-(A<1>)n'-(B<1>)m'-(A<2>)n-A<3> (II); A<1> and A<2> = gps. of formula (i); B<1> and B<2> = gps. of formula (ii); B<3> = a gp. of formula (iii); and A<3> = a gp. of formula (iv); a and b = 0 to 20; R<1> = H, 1-18C alkyl, 2-18C alkenyl, 3-18C alkynyl, 2-19C alkanoyl, 3-20C alkenoyl, 4-20C alkynoyl, 6-20C aryl, (6-14C)aryl(1-8C)alkyl or P(W)ZZ'; R<2> = H, OH, 1-18C alkoxy, halogen, azido or NH2; D = OH or OPO3<2->; B = a natural or unnatural nucleotide base; n = 1-100; n' = 0-50; m = 0-5; m' = 0-5 in (I) or 1-5 in (II); A = O, S or CH2; W = O, S or Se; V = O or S; T = O, S or NH; Y = O, S, NH or CH2; X = OH or SH; U = OH, SH, BH3 (sic), SeH, 1-18C alkoxy, 1-18C alkyl, 6-20C aryl, (6-14C)aryl(1-8C)alkyl, NHR<3>, NR<3>R<4> or (OCH2CH2)pO(CH2)qCH2R<5>; R<3> = 1-18C alkyl, 6-20C aryl, (6-14C)aryl(1-8C)alkyl or (CH2)c(NH(CH2)c)dNR<6>R<6>; c = 2-6; d = 0-6; R<6> = H, 1-6C alkyl or (1-4C)alkoxy(1-6C)alkyl; R<4> = 1-18C alkyl, 6-20C aryl or (6-14C)aryl(1-8C)alkyl; or NR<3>R<4> = a 5- or 6-membered ring opt. contg. another N, O or S atom; p = 1-100; q = 0-22; R<5> = H or a functional gp. such as OH, NH2, NHR<7>, COOH, CONH2, COOR<8> or halogen; R<7> = 1-6C alkyl, R<8> = 1-4C alkyl; Z and Z' = OH, SH, SeH, 1-22C alkoxy, O(CH2)bNHR<7>'R<8>', 1-18C alkyl, 6-20C aryl, (6-14)aryl(1-8C)alkyl (where aryl includes heteroaryl and is opt. substd. by 1-3 of COOH, NH2, NO2, 1-4C alkylamino, 1-6C alkoxy, OH, halogen and CN), 1-18C alkylthio, NHR<3>, NR<3>R<4>, a 3'- or 5'-linked nucleoside or oligonucleotide, or a gp. which enhances intracellular uptake, serves as a DNA probe label or binds to, crosslinks with or cleaves a target nucleic acid after hybridisation; R<7>'R<8>' = as R<7>, R<8>; or NR<7>'R<8> = a 3- to 6-membered ring.
Patent DK-0716074-T3 (DK)
Inventor: DRIVON GILLES
IPC: C07C69/63
Filed: 1995-11-30
Granted: 1998-12-21
Abstract: Prepn. of alkyl halo-difluoroacetates of formula CF2X-CO-OR (I), comprises reaction of 1,1-difluorotetrahaloethane of formula CF2XCY2Z (II) with an alcohol of formula ROH (III), in the presence of oxygen and a free radical generator. X = F, Cl, Br or I; R = 1-10C aliphatic hydrocarbyl; Y, Z = Cl, Br or I.
Patent DK-0756489-T3 (DK)
Inventor: KIM HYUN SOO
IPC: A61K38/12
Filed: 1995-05-19
Granted: 1999-12-06
Abstract: PCT No. PCT/KR95/00059 Sec. 371 Date Nov. 13, 1996 Sec. 102(e) Date Nov. 13, 1996 PCT Filed May 19, 1995 PCT Pub. No. WO95/32726 PCT Pub. Date Dec. 7, 1995A composition comprising 1.0 to 40 wt. % of a cyclosporin A, 0.1 to 30 wt. % of an emulsifier and 5 to 80 wt. % of a porous dextrin, based on the total weight of the composition has a remarkably improved dissolution rate and superior bioavailability.
Patent DK-0774961-T3 (DK)
Inventor: LOESCHER WOLFGANG
IPC: A61P25/08
Filed: 1995-07-27
Granted: 2003-09-01
Abstract: PCT No. PCT/DE95/00981 Sec. 371 Date Feb. 11, 1997 Sec. 102(e) Date Feb. 11, 1997 PCT Filed Jul. 27, 1995 PCT Pub. No. WO96/04897 PCT Pub. Date Feb. 22, 1996The invention relates to the use of selegiline (=L-N-(1-phenylisopropyl)-N-methyl-N-propynylamine) or pharmaceutically utilizable salts thereof in pharmaceuticals with an antiepileptic effect.
Patent DK-0737635-T3 (DK)
Inventor: FURMANSKI HORST
IPC: B65H3/08
Filed: 1996-04-12
Granted: 2000-04-03
Abstract: The device operates to separate the layers of flat material, in a stack, the lowest layer (10) is subjected to suction at the sides. This draws down the side sections (12), from the remainder of the material stack (11), before the bottom layer is released and removed.   The device is also fitted with a transport slide (15) that has a flat centre section. The side sections are parallel to the direction of movement and have a downwards slope on at least one side with an opening linked to an underpressure supply.
Patent DK-0771817-T3 (DK)
Inventor: ALEMANY MARIA
IPC: C07C69/58
Filed: 1996-10-28
Granted: 2003-07-28
Abstract: The estrogen is selected from the group consisting of estrone, diethylstilbestrol, estriol, estradiol and ethinyl estradiol; the fatty acid is selected from the group consisting of oleic, linoleic, linolenic, stearic, palmitic, palmitoleic and arachidonic acids. They mimic the function of estrone monooleate, as a signal that informs the brain of the size of fat tissue mass. Preferred compositions for intravenous injection comprise the monoester incorporated in a lipidic suspension, prepared from lipoproteins or from liposome components such a soy oil and egg phospolipids. When administered to rats with a 15% of total adipose tissue, they produce weight reduction of about 10%, by a new and unexpected mechanism. They are useful for the treatment of obesity and/or overweight in mammals, with the advantages of high efficacy and low toxicity. <IMAGE>
Patent DK-0834224-T3 (DK)
Inventor: MAATMAN JOHANNES JOZEPH
IPC: H04B7/185
Filed: 1996-06-10
Granted: 2001-01-29
Abstract: PCT No. PCT/EP96/02534 Sec. 371 Date Nov. 13, 1997 Sec. 102(e) Date Nov. 13, 1997 PCT Filed Jun. 10, 1996 PCT Pub. No. WO97/01225 PCT Pub. Date Jan. 9, 1997Known ground-station systems offer users of mobile stations a different standard procedure for each ground station. By through-coupling an aerial of the ground station to a processing arrangement of the ground station in response to a first identification code, satellite signals comprising the first identification code being processed via the processing arrangement of the ground station, and by through-coupling the aerial via a link to another processing arrangement of another ground station in response to a second identification code, satellite signals comprising the second identification code not being processed via the processing arrangement of the ground station, but only being transmitted by the ground station via the link to the other processing arrangement of the other ground station in order to be processed subsequently by the other processing arrangement at the site of the other ground station, the result is achieved that a user of a mobile station deals with one standard procedure over the entire world and a "global image" is created.
Patent DK-0839211-T3 (DK)
Inventor: SEULBERGER HARALD
IPC: C12N15/60
Filed: 1996-07-10
Granted: 2001-09-03
Abstract: PCT No. PCT/EP96/03009 Sec. 371 Date May 1, 1998 Sec. 102(e) Date May 1, 1998 PCT Filed Jul. 10, 1996 PCT Pub. No. WO97/03208 PCT Pub. Date Jan. 30, 1997The disclosure concerns a process for the microbial preparation of riboflavin by culturing riboflavin-producing microorganisms in a nutrient medium and then isolating the riboflavin which has been produced, which comprises using microorganisms in which the endogenous isocitrate lyase (ICL) activity has been altered.
Patent DK-0861280-T3 (DK)
Inventor: LEE JEAN
IPC: C09D179/08
Filed: 1996-10-30
Granted: 2002-04-08
Abstract: Thermosetting polymers with high temperature capability for composite and adhesive applications are disclosed. Inhibitors for improving pot life, gel time and storage stability are disclosed. These polymers are ideally suited for adhesives and RTM, resin film infusion, and prepreg methods to make polymer matrix, fiber reinforced composite parts.
Patent DK-1003978-T3 (DK)
Inventor: CENEY STANLEY
IPC: G01L5/00
Filed: 1998-08-17
Granted: 2010-04-26
Abstract: A fastener system (1) employs a portable sensing device (13) such as one or more reactance capacitors (15,16), which removably attaches adjacent to the fastener to detect and measure the change in a gap or specialized form of the bolt head or associated washer (26,27) caused by the relative movement of portions of the fastener system (1) when it is under strain without contacting the sensed portions undergoing the significant relative movement.
Patent DK-1025444-T3 (DK)
Inventor: LASKEY RONALD ALFRED
IPC: G01N33/574
Filed: 1998-10-21
Granted: 2005-06-27
Abstract: Methods tor determining cell growth abnormalities, particularly cancerous or pre-cancerous cells, are described in which polypeptides involved in the preinitiation complex of DNA replication are detected. Target polypeptides include CDC6, MCM2, MCM3, MCM4, MCM5, MCM6 and MCM7. Typically antibodies detecting these proteins are used in screening assays on tissue sections or smears. The detection of RNA encoding these proteins is also described. The application is particularly concerned with cervical neoplasia's but also describes screening for growth abnormalities of breast, colon, lung, bladder, skin, larynx, oesophagus, bronchus, lymph nodes and urinary tract tissue.
Patent DK-1034014-T3 (DK)
Inventor: RASMUSSEN ERIK
IPC: B09B3/00
Filed: 1998-11-25
Granted: 2002-10-28
Abstract: A process for the separation of heavy metal and halogen from unwanted waste material or residue. Halogen is selectively extracted or washed out from the waste material. Metal is selectively extracted or washed out from the essentially halogen free waste material.
Patent DK-1079350-T3 (DK)
Inventor: MAHLER HANSJUERG DR
IPC: G08B13/194
Filed: 1999-07-17
Granted: 2004-02-02
Abstract: A device has an image sensor (5), one or more presence or movement sensors (6) and an electronic controller-analyzer coupled to these sensors. Devices for detecting sabotage to any sensor store and check stable features for images picked up by the image sensor. Checking stable features is performed by testing an image of a room being monitored for stable features. Any stable features found are compared with stored images by using image-processing methods.